The complex and frequently overlapping symptoms of autoimmune diseases make them exceedingly challenging to diagnose, potentially leading to late or incorrect diagnoses and failed treatments. However, a personalized approach could offer a solution.

With autoimmune diseases affecting as many as 1 in 6 Americans alone and resulting in vast costs to healthcare systems, it is imperative that more advanced diagnostics are developed. Thankfully, advances in biomarker and diagnostic technologies are enabling more effective patient stratification, helping to ensure that patients get the most effective treatment for their specific disease, exactly when they need it.










































This site uses Akismet to reduce spam. Learn how your comment data is processed.